Rational design of an environment-sensitive fluorescent probe for monitoring butyrylcholinesterase activity and its application in Alzheimer's disease
- 1 January 2026
- journal article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (7) , 3323-3330
Abstract
LY36 integrates selective BChE inhibition with environment-sensitive fluorescence for real-time visualization of Alzheimer's pathology in biological models.Keywords
Funding Information
- National Natural Science Foundation of China (U1704185)
This publication has 31 references indexed in Scilit:
- Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2024
- Effects of Rikkunshi-To, a Japanese kampo medicine, on donepezil-induced gastrointestinal side effects in miceJournal of Pharmacological Sciences, 2022
- Conjugates of Tacrine with Salicylamide as Promising Multitarget Agents for Alzheimer's DiseaseChemMedChem, 2022
- Alzheimer’s Disease: Epidemiology and Clinical ProgressionNeurology and Therapy, 2022
- Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitorsEuropean Journal of Medicinal Chemistry, 2020
- Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2018
- N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer’s agentsBioorganic & Medicinal Chemistry, 2017
- Application of capillary electrophoresis coupling with electrochemiluminescence detection to estimate activity of leucine aminopeptidasBiomedical Chromatography, 2013
- Qualitative determination of false‐positive effects in the acetylcholinesterase assay using thin layer chromatographyPhytochemical Analysis, 2003
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961